Your browser doesn't support javascript.
Association of IFNAR1 and IFNAR2 with COVID-19 severity.
Yaugel-Novoa, Melyssa; Bourlet, Thomas; Longet, Stéphanie; Botelho-Nevers, Elisabeth; Paul, Stéphane.
  • Yaugel-Novoa M; Centre International de Recherche en Infectiologie, Team GIMAP, Université Jean Monnet, Université Claude Bernard Lyon, Inserm, Saint-Etienne, France.
  • Bourlet T; Centre International de Recherche en Infectiologie, Team GIMAP, Université Jean Monnet, Université Claude Bernard Lyon, Inserm, Saint-Etienne, France.
  • Longet S; Centre International de Recherche en Infectiologie, Team GIMAP, Université Jean Monnet, Université Claude Bernard Lyon, Inserm, Saint-Etienne, France.
  • Botelho-Nevers E; Centre International de Recherche en Infectiologie, Team GIMAP, Université Jean Monnet, Université Claude Bernard Lyon, Inserm, Saint-Etienne, France; CIC 1408 Inserm Vaccinology, University Hospital of Saint-Etienne, F42055 Saint-Etienne, France.
  • Paul S; Centre International de Recherche en Infectiologie, Team GIMAP, Université Jean Monnet, Université Claude Bernard Lyon, Inserm, Saint-Etienne, France; CIC 1408 Inserm Vaccinology, University Hospital of Saint-Etienne, F42055 Saint-Etienne, France; Immunology Department, iBiothera Reference Center, U
Lancet Microbe ; 4(7): e487, 2023 Jul.
Article in English | MEDLINE | ID: covidwho-2306113

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Lancet Microbe Year: 2023 Document Type: Article Affiliation country: S2666-5247(23)00095-2

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Lancet Microbe Year: 2023 Document Type: Article Affiliation country: S2666-5247(23)00095-2